Revance Therapeutics, Inc. (RVNC)

1d ago, source: Yahoo Finance

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q4 2023 Earnings Call Transcript February 29, 2024 Revance Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the ...

Revance Therapeutics, Inc. (NASDAQ:RVNC) is favoured by institutional owners who hold 63% of the company

7d ago, source:

Every investor in Revance Therapeutics, Inc. ( NASDAQ:RVNC) should be aware of the most powerful shareholder groups. And the ...

Revance Therapeutics: Impressive Sales Growth/Concerning Cash Burn

7mon ago, source: Hosted on MSN

Revance Therapeutics, Inc. stock has fallen by half in the past six months, despite impressive sales growth, prompting speculation on whether it is now a good buy. The recent DAXXIFY launch seems ...

Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

23d ago, source: Stockhouse

Revance Therapeutics, Inc. (NASDAQ: RVNC) today announced new hire grants totaling an aggregate of 222,452 inducement restricted stock units (“RSUs”) to 29 employees. The RSUs ...

Revance Therapeutics Inc RVNC

7d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Revance Therapeutics Inc.

23d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Revance Therapeutics, Inc. Common Stock (RVNC)

10y ago, source: Nasdaq

*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...

Revance Therapeutics Inc RVNC

16d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Revance Therapeutics, Inc. (RVNC)

7d ago, source: Yahoo Finance

*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...